FDA considering approval of first over-the-counter birth control pill

Accessing birth control pills could soon become a lot easier in America.

Advisers to the Food and Drug Administration (FDA) will meet next week to evaluate drugmaker HRA Pharma's application for its decades-old daily birth control pill Opill to be sold in the U.S. without requiring a prescription.

The public meeting is one of the final steps before the FDA makes a decision, but concerns raised by the agency in an initial review published Friday indicate the approval is not guaranteed.